| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Australia | 2 | |
| #4 | Brazil | 2 | |
| #5 | Canada | 2 | |
| #6 | China | 2 | |
| #7 | EPO (European Patent Office) | 2 | |
| #8 | Israel | 2 | |
| #9 | Republic of Korea | 2 | |
| #10 | Mexico | 2 | |
| #11 | Philippines | 2 | |
| #12 | South Africa | 2 | |
| #13 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tenor Hermann | 21 |
| #2 | Naef Reto | 21 |
| #3 | Hermann Tenor | 5 |
| #4 | Reto Naef | 5 |
| #5 | Martini Elia | 1 |
| #6 | Spoerri Michael | 1 |
| #7 | Koch Guido | 1 |
| #8 | Di Maio Selena | 1 |
| #9 | Peterke Jeanette | 1 |
| #10 | Lone Esra | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020109354A1 | Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof | |
| CN110621676A | Novel dual mode of action of soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof | |
| BR112018009805A2 | 2-phenyl-3,4-dihydropyrrolo [2,1-f] [1,2,4] triazinone derivatives as phosphodiesterase inhibitors and uses thereof |